Introduction
Spinal cord injury (SCI) is a complicated and devastating neuropathological condition.
Etiologically, more than 90% of SCI cases are accidentally traumatic events [1] .
Clinically, SCI affects the spinal cord on the cervical level, thoracic level and lumbar level. The pathophysiology of SCI comprises initial injury (primary phase) and the delayed tissue injury (secondary phase) [2] . Moreover, the secondary injury has been well-documented to be critical for the interference of SCI progression, including but not limited to excitotoxicity, oxidative stress, inflammation, and extracellular matrix synthesis [3] . Among these phenomena, pro-inflammatory cytokines like tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β) can be secreted by neurons, astrocytes and microglial cells in the central nervous system (CNS) [4] . Microglial cells are the resident immune cells of CNS and become activated in response to damage [5] . Even though SCI patients often survive for decades after the initial injury with good health care, it causes tremendous economic pressure, mental stress and social burden [6] . Therefore, it is critical to develop new effective treatments for SCI through unraveling more cellular and molecular mechanisms of SCI.
Long noncoding RNAs (lncRNAs) are a class of regulatory RNAs with longer than 200 nucleotides in length and have recently been characterized as key modulators of CNS injuries including SCI [7] . In SCI, the expression profiles of lncRNAs have been revealed after SCI at different phases, as well as their functional roles, especially in glial activation and neuronal apoptosis [8] . LncRNA X-inactive specific transcript (XIST) is an acknowledged cancer-related gene in various cancers [9] . Recently, several researches have declared the association between XIST expression and the development of SCI [10] [11] [12] . However, expression and role of XIST in SCI remain to be well revealed, especially in microglial cells.
As the most-studied noncoding RNA, microRNAs (miRNAs) have also been better-annotated in SCI-evoked dysregulation of cells and tissues [7] . miRNAs are a J o u r n a l P r e -p r o o f subtype of transcripts containing approximate 22 nucleotides and regulate functional genes via binding to 3′ untranslated region (3′UTR) of target mRNAs in a Dicer-dependent manner. New insights into miRNAs related to SCI have early been announced, as well as its roles [13, 14] . MiRNA-27a-3p (miR-27a) has been reported to be abnormally expressed in SCI progressions, including inflammatory response, blood-spinal cord barrier and drug response [15] [16] [17] . Besides, it is extensively recognized that miR-27a participates in lipopolysaccharide (LPS)-induced multiple cell injuries including microglial cells [18] . LPS is extensively used in models studying inflammation, including neuroinflammation [19] . Besides, XIST has also been involved in LPS-stimulated chronic constriction injury in rat microglial cells [20, 21] . Whereas, there is little information elaborating the interaction between XIST and miR-27a, especially in SCI.
SCI models induced by LPS have been widely used for exploring the pathogenesis of SCI and testing new therapeutic medicine for SCI. Moreover, smad ubiquitination regulatory factor 1 (Smurf1) is associated with apoptosis in acute SCI, and its role in LPS-induced neurons has been documented [22] , which perhaps depends on miRNAs regulation [23, 24] . Thus, we detected expression of XIST in SCI models in rats and LPS-induced microglial cells, as well as its role in cell viability, apoptosis and inflammatory cytokines resection. Notably, we attempted to investigate the interplay among XIST, miR-27a and Smurf1 in SCI-evoked apoptosis and inflammatory injury.
Materials and methods

Establishment of rat model
This study was approved by the Experimental Animal Ethics Committee of The First People's Hospital of Lianyungang. A total of 12 male Sprague-Dawley rats (weight, 210-250 g; age, 9-11 weeks) and 5 embryonic Wistar rats (weight, 70-120 g; age 3-5 weeks) were purchased from Shanghai Laboratory Animal Company (Shanghai, J o u r n a l P r e -p r o o f China), and housed according to the guidelines of the National Institute of Heath's Guide for the Care and Use of Laboratory Animals. The SCI model has been previously described [25, 26] . Briefly, the rats were randomly divided into four groups (3 rats/group): sham, SCI, SCI+sh-NC and SCI+sh-XIST. The rats involved SCI operation were anesthetized with chloral hydrate (Sigma-Aldrich, St. Louis, MO, USA) via intraperitoneal injection (0.6 ml/100 g) and placed in a prone position.
Briefly, vertebral T9-12 were exposed and a laminectomy was performed at the thoracic level T10. SCI was induced by a standard 10 g instrument with the diameter of 25 mm (New York University Impactor) was used to induce weight-drop injury. In SCI+sh-XIST/NC groups, the SCI rats were immediately injected with 5 μL of sh-XIST/NC GenePharma (Shanghai, China) into the injured sites. The sham rats were received laminectomy but not hitting T10. All rats were sutured after surgery.
After 3 days, hindlimb locomotor activity of all rats was evaluated by 21-point Basso-Beattie-Bresnahan Locomotor Rating Scale (BBB) and were euthanized with an overdose of chloral hydrate (10 mg/kg; Sigma-Aldrich). Then, the spinal cord tissues (10 mm long segment centered T10) were harvested for total RNA and total protein isolation. The sequence of shRNAs was presented in Table 1 .
Isolation of microglial cells
The central nervous system (CNS) of embryonic Wistar rats were stripped out and were digested in 0.025% trypsin (Invitrogen, Carlsbad, CA, USA) for 1 h. The supernatant was loaded in culture dishes, and cultured in high-glucose Dulbecco's Modified Eagle's Medium (Gibco, Grand Island, NY, USA) containing 20% fetal bovine serum (Gibco) with shaking on an orbital shaker. The medium was changed with fresh medium every 3 days. After 14 days, the cells were passaged and the microglial cells in passage 3-7 were collected for further studies.
Real-time quantitative PCR (RT-qPCR)
Total RNA in tissues and cultured cells was isolated by RNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the instructions. After determination of the J o u r n a l P r e -p r o o f concentration and purity, 500 ng RNA sample was reversely transcribed into cDNA using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA), followed with amplification of cDNA with iQ SYBR Green Supermix (Bio-Rad) on a Bio-Rad iCycler. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA and U6 small nuclear RNA (U6) was used as an internal control to XIST/Smurf1 mRNA and mature miR-27a, separately. The reactions were performed in triplicate for each sample, and the primers were presented in Table 1 . The relative gene expression was analyzed using the threshold cycle 2 ∆∆Ct method and the results were presented as fold changes normalized to control groups.
LPS-induced cell model
Commercial lipopolysaccharide (LPS; L4391) from Escherichia coli 0111:B4 was purchased from Sigma-Aldrich and stock solution of LPS (100 μg/mL) was prepared in cell culture medium. For SCI cell model, the primary microglial cells (80% confluence) were subjected with 1 μg/mL of LPS for 24 h.
Cell viability analysis (SRB assay)
LPS-treated microglial cells were collected to evaluate cell viability using sulforhodamine B (SRB) assay. Briefly, the cell culture medium was added with 0.4 mL cold trichloroacetic acid (TCA; 10%; Sigma-Aldrich) with incubation for 1 h at 4°C. After washed with water, the cells were stained with 400 µL SRB (0.4%;
Sigma-Aldrich) solution in 1% acetic acid (Thermo Fisher Scientific, Waltham, MA, USA) with incubation for 15 min at room temperature. After washed with 1% acetic acid, the stained cells were solubilized with 10 mM Tris base (Sigma-Aldrich). The absorbance was examined at 510 nm on Benchmark Plus™ microplate spectrometer (Bio-Rad). Every group was repeated with at least three times and the results were presented as percentages compared to control groups.
Flow cytometry
LPS-treated microglial cells were collected to evaluate cell apoptosis using flow (cleaved-casp-3; #49822, 1:500), and anti-GAPDH (#181603, 1:10, 000 ) from Cell
Signaling Technology (Danvers, Massachusetts, USA). GAPDH served as calibration.
The band density was scanned and measured using Fluorchem 5500 software (Alpha Innotech Co., San Leandro, CA, USA). The relative protein level was presented as fold change normalized to control group.
Enzyme-linked immunosorbent assay (ELISA)
The culture medium of LPS-treated microglial cells was collected to evaluate inflammatory cytokines release. The concentrations of TNF-α (CSB-E11987r) and IL-6 (CSB-E04640r) were measured by commercial ELISA kits from Cusabio Biotech Co. (Wuhan, China). Each group was repeated three times and the absorbance at 450 nm was read using Benchmark Plus™ microplate spectrometer (Bio-Rad).
Cell transfection
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Special siRNA against XIST (si-XIST), miR-27a mimic, and miR-27a inhibitor (anti-miR-27a) were obtained from GenePharma (Shanghai, China), as well as their negative controls. The pcDNA4.1 vector was purchased from Thermo Fisher Scientific and the overexpression vector pcDNA-Smurf1 was constructed. Uniformly, 30 nM of miRNAs, 50 nM siRNAs or 2 μg vectors were transfected into microglial cells using Lipofectamine RNAi MAX (Invitrogen). As for rescue assays, half nucleotides or vectors were co-transfected into microglial cells. Transfected cells were incubated for 24 h for further study. The sequence of siRNAs was presented in Table   1 .
Dual-luciferase reporter assay
The putative complementary sites in XIST and the 3' untranslated region of Smurf1 (Smurf1 3'UTR) were mutated using Site-Directed Mutagenesis Kit (SBS Genetech, Beijing, China). Then the wild type (WT-) of XIST and Smurf1 and their mutant type (MUT-) were separately inserted into pIS0 luciferase reporter vector (Invitrogen).
Microglial cells were co-transfected with miR-27a/NC mimic and either WT/MUT-XIST or WT/MUT-Smurf1 3'UTR for 24 h. Meanwhile, an internal control pRL-β-actin was transfected into microglial cells combined with miR-27a/NC mimic for 24 h. The luciferase activities were measured on dual-luciferase reporter assay system (Promega, Madison, Wisconsin, USA). Every group was repeated in three times and the data was presented as fold change normalized to control group.
RNA immunoprecipitation (RIP) and RNA pull-down
For RIP assay, microglial cells were transfected with miR-27a mimic for 24 h, and the cell extract was acquired to incubate with magnetic beads conjugated with argonaute 2
Ago2 or immunoglobulin G (IgG) antibody (Millipore) in RIP buffer. After incubation of proteinase K, the immunoprecipitated RNAs were detected by RT-qPCR.
Oligonucleotides miR-27a and its mutant type were obtained by in vitro transcription, as well as its negative control. Biotin labelled miR-27a-WT/MUT and miR-NC were J o u r n a l P r e -p r o o f obtained by biotin-labeled RNA labeling mix (Roche, Basel, Switzerland). 10 nm of biotinylated (bio-) miRNAs were transfected into microglial cells for 24 h. The cells were harvested and lysed, then incubated with streptavidin dynabeads. Then the supernatant was discarded and the beads were washed with washing buffer. RNA samples pulled down were subjected into RT-qPCR.
Statistical analysis
The data was presented as the mean ± standard deviation and statistics were analyzed by SPSS 21.0 (SPSS Inc, Chicago, IL, USA). Student's t-test and one-way analysis of variance were utilized for comparison between two groups and in multiple groups, respectively. P < 0.05 was considered as statistically significant.
Results
XIST was highly expressed in SCI models in vitro and in vivo
SCI models were established in rats and primary microglial cells. As shown in Figure   1A , hindlimb locomotor activity was dramatically inhibited after spinal cord contusions as described by the decrease of BBB score, suggesting a triumphant building of SCI model in vivo. Moreover, expression of XIST was significantly higher in spinal cord tissues from SCI rats (n=3) than that from sham rats (n=3) ( Figure 1B) .
Additionally, XIST level was noticed to be upregulated in LPS-induced primary microglial cells isolated from the normal CNS tissues of neonatal rats ( Figure 1C) .
Notably, the cell behaviors were measured after 1 μg/mL of LPS stimulation for 24 h, as well. SRB assay and flow cytometry analysis showed an approximate 60% cell viability inhibition and about 12% apoptosis rate promotion in LPS-induced microglial cells ( Figure 1D and 1E) . Meanwhile, the cells subjected with LPS exhibited lower Bcl-2 level and higher Bax and cleaved caspase 3 levels than control cells ( Figure 1F ). In terms of inflammation, the secretion of inflammatory cytokines TNF-α and IL-6 was abundantly promoted with LPS treatment ( Figure 1G ).
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According to these detection ( Figure 1D-1G 
Knockdown of XIST alleviated LPS-induced apoptosis and inflammatory injury in primary microglial cells
To evaluate the role of XIST in SCI cell models, the primary microglial cells were transfected with si-XIST to knockdown XIST expression, followed with 1 μg/mL of LPS stimulation. RT-qPCR tested the transfection efficiency, and results showed XIST level was obviously depressed in LPS-induced microglial cells (Figure 2A ).
Functionally, si-XIST transfection weakened the loss of cell viability induced by LPS ( Figure 2B) ; moreover, LPS-induced cell apoptosis was inhibited with XIST silencing as evidenced by decreased apoptosis rate, and reduced expression of Bax and cleaved caspase 3, as well as elevated Bcl-2 level ( Figure 2C and 2D) . Consistently, TNF-α and IL-6 secretions were attenuated in LPS-treated microglial cells due to XIST deletion ( Figure 2E ). These results indicated a protective role of XIST knockdown in LPS-induced apoptosis and inflammatory injury in primary microglial cells.
XIST negatively regulated miR-27a expression via sponging
Plenty of studies identified miR-27a is involved in inflammation, especially as an LPS-sensitive miRNA. Then, we wondered whether XIST exerted its functions through regulating this miRNA. Depending on bioinformatics algorithms of starbase (http://starbase//lncRNA&flag=target&clade=Xist), there was a potential target site of miR-27a in XIST, as shown in Figure 3A . Furthermore, this putative complementary Figure 3C and 3D) . Besides, miR-27a expression level was increased in microglial cells transfected with si-XIST ( Figure 3E ). Collectively, XIST might negatively regulate miR-27a expression via sponging. Next, the basic expression of miR-27a in SCI models was detected as well. RT-qPCR data depicted that miR-27a was lowly expressed in SCI rats and LPS-induced microglial cells ( Figure 3F and 3G) . These results suggested a potential XIST/miR-27a axis in SCI.
Smurf1 was negatively regulated by miR-27a via targeting
The downstream targets of miR-27a were also verified. Bioinformatics analysis of starbase (http://starbase/mir-27a-3p&clipNum=&target) showed a potential target site of miR-27a in 3'UTR of Smurf1 ( Figure 4A ). Dual-luciferase reporter assay showed that only the relative luciferase activity of vector containing WT-Smurf1 3'UTR in microglial cells was distinctively declined when co-transfection with miR-27a mimic ( Figure 4B ). The regulatory effect of miR-27a on Smurf1 was investigated by RT-qPCR and western blotting. After transfection of miR-27a mimic, Smurf1 mRNA expression and protein expression were attenuated in microglial cells ( Figure 4C-4E) ;
whereas, anti-miR-27a transfection exerted the opposite effect on Smurf1 expression levels. Taken the above results together, miR-27a might directly regulate Smurf1 expression. Next, the basic expression of Smurf1 in SCI models was detected. The data from three SCI rats depicted that Smurf1 expression was highly expressed ( Figure 4F and 4G) . Similarly, the mRNA and protein levels of Smurf1 were promoted in LPS-induced microglial cells ( Figure 4H and 4I) . These results suggested a potential miR-27a/Smurf1 axis in SCI.
Smurf1 mediated the role of XIST in LPS-induced apoptosis and inflammatory injury in primary microglial cells via miR-27a
Here, we hypothesized a potential interaction among XIST, miR-27a and Smurf1 in SCI. Therefore, primary microglial cells were transfected with si-XIST alone or together with anti-miR-27a or pcDNA-Smurf1, and then subjected with 1 μg/mL of J o u r n a l P r e -p r o o f LPS for 24 h. First of all, Smurf1 expression was monitored and analyzed among groups. As shown in Figure 5A and 5B, Smurf1 expression both on mRNA level and protein level was downregulated by XIST knockdown mediated by si-XIST transfection, and this impact was partially reversed with co-transfection with either anti-miR-27a or Smurf1 overexpression vector. This finding suggested a regulatory effect of XIST on Smurf1 expression via miR-27a. Then, a series of rescue experiments were carried out. SRB assay demonstrated that XIST knockdown-induced cell viability recovery was abrogated in LPS-treated microglial cells introduced Smurf1 or deleted miR-27a ( Figure 5C ). The inhibition of cell apoptosis stimulated by XIST deletion was improved with Smurf1 ectopic expression or miR-27a downregulation, as evidenced by increased apoptosis rate and enhanced
Bax and cleaved caspase 3 levels ( Figure 5D -5F). Expectedly, TNF-α and IL-6 release was inhibited by XIST knockdown, which was further partially reversed by pcDNA-Smurf1 transfection or anti-miR-27a transfection ( Figure 5G ). These results indicated the protective effect of XIST knockdown in LPS-induced microglial cells could be abolished by Smurf1 upregulation through XIST/miR-27a/Smurf1 axis.
XIST knockdown mitigated the apoptosis and inflammatory injury of SCI rats through miR-27a/Smurf1 axis
Last but not the least, it was unclear whether XIST dysregulation could further alter SCI progression in rats. The SCI rats (n=3) were injected with lentivirus vectors containing sh-XIST or sh-NC into the intrathecal space for 3 days. BBB scores were raised in SCI+sh-XIST group ( Figure 6A ). Spinal cord tissues were isolated after injection and exhibited lower level of XIST and Smurf1, and higher level of miR-27a
( Figure 6B and 6C) . Moreover, we observed that Bax and cleaved caspase 3 expression was upregulated in SCI tissues, as well as TNF-α and IL-6 secretion ( Figure 6C and 6D ). These outcomes implied that XIST knockdown functioned protective effect in SCI-evoked apoptosis and inflammatory injury in vivo depending on Smurf1 downregulation and miR-27a upregulation.
Discussion
Recently, lncRNAs have been new insight in the development of SCI-evoked inflammation, especially in microglia. For example, lncRNA MALAT1 was uncovered to be highly expressed in injured spinal cord tissues and LPS-induced microglia, and this upregulation promoted pro-inflammatory cytokines TNF-α and IL-1β release through downregulating miRNA-199b and activating IKKβ/NF-κB signaling pathway [27] . Yu et al. [28] showed the downregulation of lncRNA TUSC7
in spinal cord tissue of SCI rats and HAPI cells induced by LPS, and the suppressive role of TUSC7 in microglia-activated inflammatory response. Jiang et al. [29] also pointed out the association between lncRNA SNHG5 and microglia viability.
Therefore, we attempted to figure out the expression and role of XIST in injured spinal cord rat tissues and LPS-activated microglial cells isolated from normal neonatal rats, as well as its hidden mechanism through acting as a miRNA "sponge".
In this study, we demonstrated that XIST was significantly upregulated in injured spinal cord and microglia after SCI, which was similar to the data in chronic constriction injury model from Yan et al. [11] Besides, Gu et al. [12] identified XIST as the most upregulated lncRNA in rat spinal cord segments at the contusion epicenter.
Thereby, now available researches all suggest that XIST is deregulated and highly induced after SCI. In consideration of its biological role, knockdown of XIST was declared to reduce rat SCI. For instance, inhibiting XIST might suppress neuronal apoptosis by targeting miRNA-494 in PTEN/AKT/mTOR pathway [12], attenuate neuroinflammation through targeting ZEB1 and inhibiting COX-2, TNF-α and IL-6 [11] , and accelerate neuropathic pain by sponging of miRNAs [10] . Here, we observed that decreased XIST could promote cell viability, and restrain apoptosis and secretion of TNF-α and IL-6 in LPS-induced microglial cells, as well as improve the locomotor activity of SCI rats. Notably, miR-27a was clarified as a novel target for XIST. Taken these outcomes together, XIST downregulation exerts universe J o u r n a l P r e -p r o o f protective role in neurons and microglia after SCI via several molecular mechanisms including targeting miRNAs.
Previous studies have well-documented about the involvement of miR-27a in LPS-induced inflammation in several types of cells, including pancreatic acinar cells [30] , thyroid follicular epithelial cells [31] , bronchial epithelium cells [32] , macrophages [33] and microglia [18] . According to investigation from Lv et al. [18] , miR-27a was rapidly decreased in primary microglial cells under LPS stimulation, and this lower expression increased the production of IL-6, IL-1β, TNF-α, and NO.
Consistently, we noticed downregulation of miR-27a in both LPS-induced primary microglial cells and SCI rats. Moreover, miR-27a deletion by transfection could abolish the suppressive effect of XIST knockdown on apoptosis and inflammatory response in SCI cell model in microglia. Expression of this miRNA was also distinctively improved in spinal cord tissues after injected with sh-XIST. All in all, our data suggested that miR-27a might function as an anti-inflammatory role in SCI, which was in line with outcome from Zhang et al. [16] . In that study, decreased miR-27a was found in the serum from patients with SCI and in H2O2-treated astrocytes; ectopic miR-27a inhibited TNF-α and IL-6 expression in H2O2-inflammatory injury in astrocytes by targeting toll-like receptor 4, which is closely related to inflammatory response. Additionally, miR-27a was indicated to take part in other inflammatory conditions, such as autoimmune encephalomyelitis [34] , spinal cord glioblastoma [15] , and spinal cord ischemia reperfusion [17] .
In this study, we dug out Smurf1 was the functional gene underlying XIST/miR-27a axis during SCI. First of all, Smurf1 was identified as a downstream target gene of miR-27a. Then, restoration of Smurf1 mediated by pcDNA-Smurf1 transfection or anti-miR-27a transfection could partially but significantly reverse the inhibitory activities of XIST knockdown on cell apoptosis and inflammatory cytokines IL-6 and TNF-α secretion. This implied a novel XIST/miR-27a/Smurf1 pathway in the development and treatment of SCI. Smurf1 is an important regulator of multiple J o u r n a l P r e -p r o o f biological signaling pathway such as TGF-β, TLR and BMP [35] . Besides, Li et al. [36] announced that Smurf1 was low expressed in normal spinal cord, but increased at 6 h after SCI, and peaked at 1 day till 3 days, which suggested a key role of Smurf1 in the pathophysiology of SCI. Furthermore, the promoting role of Smurf1 in LPS-induced neuroinflammation was expounded in neuronal necroptosis in PC12 cells [22] . Here, we demonstrated a similar role of Smurf1 in apoptosis and inflammation in injured spinal cord and LPS-treated microglia.
In terms of SCI cell model, LPS-induced microglia was utilized to mimic the activation of microglia in SCI-evoked inflammatory injury. However, the marker of activated microglia Iba-1 [27] was not confirmed in the current studies, even though LPS-induced cell models in neurons, astrocytes and microglia have been well-acknowledged. Besides, the underlying signaling pathways remain to be further investigated as well, such as IKKβ/NF-κB, TGF-β, TLR and BMP.
In conclusion, we found that XIST was upregulated in SCI models in rats and LPS-activated microglia. Functionally, knockdown of XIST could suppress cell apoptosis and inflammatory response presumably through sponging miR-27a and downregulating Smurf1 both in vitro and in vivo. Our results provide a novel XIST/miR-27a/Smurf1 pathway, suggesting a target for the development and treatment of SCI.
Author contributions
Conceptualization and funding acquisition, Qin Zhao, Qinglun Su and Fei Lu;
Methodology, Zhen Liu, Xiaomei Xia, Zhenzhuang Yan; Formal analysis, ang Zhou, Rujie Qin.
Funding
None.
J o u r n a l P r e -p r o o f 
